Introduction
============

The genus of *Legionella* is relatively diverse with 58 member species, 29 of which are known to cause disease in humans ([@ref-24]). Legionellosis, infection with a member of the genus, can result in a form of pneumonia known as Legionnaires' disease or the less severe, flu-like disease known as Pontiac fever. The first *Legionella* was identified following an outbreak of Legionnaires' disease in 1976, and named *Legionella pneumophila* ([@ref-39]). This species is responsible for a large proportion of Legionnaires' cases, can often require hospitalization and is particularly dangerous for immuno-compromised patients ([@ref-68]).

All *Legionella* spp. have a common association with water sources, surviving within amoebae, protozoa or slime moulds ([@ref-35]). Their association within microbial biofilm communities is also beneficial for their ability to survive and cause disease ([@ref-16]; [@ref-52]). This close association between bacteria and protozoan host has led to a number of horizontal gene transfer events, significantly contributing to the intracellular fitness of these bacteria ([@ref-19]; [@ref-15]; [@ref-41]). Disease outbreaks often occur following contamination of industrial systems that help to spread the bacteria as infectious aerosols ([@ref-38]; [@ref-59]). Following phagocytosis by eukaryotic cells, the bacteria are able to survive intracellularly, which is essential for disease progression.

Secondary metabolites are often small chemical compounds produced by a biosynthetic gene cluster (BGC), often consisting of either polyketide synthases (PKS) or non-ribosomal peptide synthetases (NRPS). These compounds are often not essential for survival but might have significant roles in niche adaptation and virulence. Briefly, PKS and NRPS are multifunctional enzymes that catalyze the condensation of carboxylic acid (PKS) ([@ref-46]) or amino acid (NRPS) building blocks ([@ref-75]). PKS catalyze the formation of C-C bonds via the condensation of malonyl and acyl subunits that are enzyme bound, as in the case of type I PKS, which show similar protein domain architecture to eukaryotic fatty acid synthases (FAS). The catalytic functions of PKS and NRPS are organized in modules, with each module responsible for the incorporation and processing of one individual building block (different acyl or malonyl units for PKS or amino acids for NRPS). Due to these similar biochemical principles, hybrids of PKS and NRPS are also possible ([@ref-29]). The biosynthesis of PKS and NRPS derived natural products as well as fatty acids requires specialized phosphopantetheinyl transferases (PPTases) that catalyze the post-translational transfer of the 4′-phosphopantetheinyl group from coenzyme A (CoA) to acyl (acyl carrier protein (ACP)) or peptidyl (peptidyl carrier protein (PCP)) carrier proteins also called thiolation (T) domains. These are components of the enzyme complexes of FAS, PKS and NRPS ([@ref-58]; [@ref-57]) and covalently link the biosynthesis intermediates to the enzyme complexes. PPTases in bacteria are classified as acyl carrier protein synthase (AcpS) or Sfp (required for surfactin production in *Bacillus subtilis*) enzymes and exhibit different substrate specificities. Sfp-PPTases are monomeric enzymes of approximately 240 aa ([@ref-57]) that were shown to activate all kinds of T domains from FAS, PKS and NRPS by attachment of a phosphopantetheinyl group. AcpS PPTases on the other hand, are only half the size and are only functional for ACPs from FAS and type II PKS ([@ref-40]; [@ref-58]; [@ref-57]). Therefore, most bacteria (especially those producing secondary metabolites) have two or more PPTases encoded in their genome.

The presence of PKS and NRPS is well established in all types of bacteria, for example, *Streptomyces*, *Mycobacteria, Myxobacteria, Pseudomonas* and *Bacillus*. Often these products are essential in a particular facet of their respective lifecycles. From *Legionella*, only four BGCs have been explored in detail with three secondary metabolites structurally elucidated to date ([Fig. 1](#fig-1){ref-type="fig"}) ([@ref-1]; [@ref-74]; [@ref-11]; [@ref-50]). Legioliulin (1), a product of a *trans*-AT PKS cluster first identified in *L. dumoffii,* was reported originally in 2004 ([@ref-3]) and biological activity assays failed to determine a role for the compound beyond fluorescence ([@ref-1]). This study investigated the possibility that legioliulin is required for intracellular survival and ultimately failed to assign a biological function. On the other hand, a transposon mutagenesis library of *L. pneumophila* revealed a polyketide that interferes with lysosomal degradation during infection of both protozoa and macrophages ([@ref-74]). Legiobactin (2) is a siderophore involved in iron sequestration ([@ref-20]) and the unusual polyketide legionellol A (3) is involved in sliding motility and might additionally act as a surfactant ([@ref-50]). Despite all *Legionella* strains containing several BGCs, no further research has explored the roles of their respective products. To attempt to further explore the possibility that secondary metabolites are an important part of the *Legionella* lifecycle, we performed genome-wide comparisons of 15 genome sequences from *Legionella*, paying particular attention to the prevalence of BGCs. We explore possible structures and functions for these BGCs.

![Structures of the known *Legionella* natural products legioliulin, legionellol and legiobactin as well as PPTase inhibitor used in this study (4--6).](peerj-04-2720-g001){#fig-1}

Materials and Methods
=====================

Culture conditions and DNA methods
----------------------------------

The *Legionella* strains *L. pneumophila* JR32 ([@ref-67]) and Δ*icmT* ([@ref-71]), *L. longbeachae* NSW150 and *L. parisiensis* DSM 19216 were grown in N-(2-acetamido)-2-aminoethanesulphonic acid (ACES) yeast extract (AYE) broth ([@ref-32]) or on buffered charcoal yeast extract agar (Difco, Detroit, MI, USA) for three days at 37 °C. *E. coli* BL21 Star (DE3) (Novagen) was cultured in LB medium supplemented with 40 μg/mL kanamycin (Kan) and 100 μg/mL Ampicillin (Amp) (Carl Roth, Karlsruhe, Germany), if necessary. Cells were harvested and DNA was extracted using the Puregene Yeast/Bacteria Kit B (Qiagen) according to the manufacturer's recommendations.

Genome sequencing, assembly and annotation
------------------------------------------

Shotgun sequencing of *Legionella parisiensis* DSM 19216 was performed using a Genome Sequencer FLX (Roche) by MWG Genomics (Munich). Assembly was performed using the Celera Assembler (v5.3) and quality assessed using QUAST ([@ref-44]). Sequencing yielded a total of 290,164 reads with average read length of 353 bp. The *L. parisiensis* genome was assembled into a total of 226 contigs (115 ≥ 1 kb) with an N50 of 65,672 bp and a predicted genomic coverage of 25. Genome annotation was performed using prokka (v1.12) ([@ref-70]). Abricate was used to identify common antibiotic resistances (<https://github.com/tseemann/abricate>).

Phylogenetic analysis
---------------------

Fourteen *Legionella* genomes were downloaded from NCBI ([Table 1](#table-1){ref-type="table"}), their protein fasta files extracted and together with *L. parisiensis*, ortholog families were identified using proteinortho5 ([@ref-53]). Protein singletons identified in only a single species were removed from further analysis. The presence or absence of all ortholog families were used to generate a gene content tree using the binary function associated with RAxML ([@ref-80]) and the gamma model of rate heterogeneity and a random number seed for parsimony inferences. Protein sequences of the ACPs of *E. coli* (ACPS, [WP_000986025.1](WP_000986025.1)) and *Bacillus subtilis* (Sfp-like, [WP_003234549.1](WP_003234549.1)) were taken from the NCBI website and used to identify homologs in each species with Blastp. Protein sequences were aligned using ClustalW, and phylogenetic trees of the PPTases were created using the PhyML plugin attached to Geneious (v6.1.6) ([@ref-43]). Branch formation was supported with bootstrapping (n = 1,000).
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All genome details for *Legionella* spp. used in this study.

![](peerj-04-2720-g007)

  Species                                                             Genome accession no.                                             Source                                            Reference
  ------------------------------------------------------------------- ---------------------------------------------------------------- ------------------------------------------------- ------------
  *Legionella anisa* str. Linanisette                                 [NZ_CANP00000000.1](NZ_CANP00000000.1)                           Clinical sample                                   [@ref-60]
  *Legionella cherrii* DSM19213                                       [NZ_JHYM00000000.1](NZ_JHYM00000000.1)                           Thermally altered water                           [@ref-8]
  *Legionella drancourtii* LLAP12                                     [NZ_ACUL00000000.2](NZ_ACUL00000000.2)                           Environmental water source                        [@ref-41]
  *Legionella fairfieldensis* ATCC49588                               [NZ_JHYC00000000.1](NZ_JHYC00000000.1)                           Cooling tower                                     [@ref-82]
  *Legionella geestiana* DSM21217                                     [NZ_JHYN00000000.1](NZ_JHYN00000000.1)                           Domestic hot water                                [@ref-26]
  *Legionella lansingensis* DSM19556                                  [NZ_JHWF00000000.1](NZ_JHWF00000000.1)                           Clinical sample                                   [@ref-83]
  *Legionella longbeachae* NSW150                                     [NC_013861.1](NC_013861.1), [NC_014544.1](NC_014544.1)           Clinical sample                                   [@ref-14]
  *Legionella moravica* DSM19234                                      [NZ_AUHS00000000.1](NZ_AUHS00000000.1)                           Cooling tower                                     [@ref-87]
  *Legionella norrlandica* strain LEGN                                [NZ_JNCF00000000.1](NZ_JNCF00000000.1)                           Biopurification system of wood processing plant   [@ref-63]
  *Legionella oakridgensis* ATCC33761                                 [NZ_CP004006.1](NZ_CP004006.1), [NZ_CP004007.1](NZ_CP004007.1)   Cooling tower                                     [@ref-10]
  *Legionella pneumophila* subsp. *pneumophila* str. Philadelphia 1   [NC_002942.5](NC_002942.5)                                       Clinical sample                                   [@ref-19]
  *Legionella sainthelensis* ATCC35248                                [NZ_JHXP00000000.1](NZ_JHXP00000000.1)                           Surface water                                     [@ref-13]
  *Legionella shakespearei* DSM23087                                  [NZ_AREN00000000.1](NZ_AREN00000000.1)                           Cooling tower                                     [@ref-84]
  *Legionella wadsworthii* DSM21896                                   [NZ_JNIA00000000.1](NZ_JNIA00000000.1)                           Clinical isolate                                  [@ref-30]
  *Legionella parisiensis* DSM19216                                   [LSOG00000000](LSOG00000000)                                     Cooling tower                                     This study

Cloning and expression of LparPPTase
------------------------------------

pCOLA_Duet1 (Novagen) was used as a vector for overproduction of the PPTase from *L. parisiensis*. The PPTase gene was amplified using primers Lpar_PPtase_Fw\_*Sac*I (GAGCTCGATGATCATTACCGAATTTAACCCT) and Lpar_PPtase_Rv\_*Pst*I (GTTCTGAATTAGGGGCAACGTGTCGAC) (synthesized by Sigma-Aldrich, St. Louis, MI, USA). Both the PCR product obtained and pCOLA_Duet1 were digested with *Sac*I and *Pst*I (Fermentas). Digestion products were separated by gel electrophoresis and desired fragments isolated with Gene JETGel extraction kit (Fermentas). Isolated fragments were ligated for 1 h at room temperature using T4-ligase (Fermentas). After ligation, *E. coli* DH10B was transformed with the ligation mixtures in a 1 mm cuvette by electroporation at 1,250 V, 200 Ω and 25 μF. Cells were plated on LB-Kan agar and incubated overnight at 37 °C. Colonies were picked and inoculated in LB-Kan media for plasmid extraction. The plasmids obtained were sequenced, and pCOLA_LparPPTase plasmids transferred into *E. coli* BL21 Star. Positive colonies were picked and cells were transformed with pUC18_indC ([@ref-5]) and grown on LB-Kan-Amp agar. Cells were grown to an OD~600~ of 0.5 at 37 °C at which time cultures were induced with 0.1 mM isopropyl-β-D-thiogalactopyranoside (IPTG) (Fermentas), and the cultures were incubated at 16 °C overnight. Following induction of LparPPTase in pUC18_indC, cells were pelleted and resuspended in deionized water for easy visualization of the blue pigment produced by IndC.

*Legionella* in vivo inhibition
-------------------------------

*L. parisiensis* was grown to an OD~600~ of 0.1 in 200 μl AYE broth in a 96-well plate at 37 °C. Putative PPTase inhibitors 4--6 ([@ref-36]) were then added in different concentrations, and the cells were allowed to grow for 24 h. For visualization of legioliulin production in *L. parisiensis*, the cells were illuminated with long-wave UV-light. The MIC of the PPTase inhibitors were tested in triplicate on *L. parisiensis, L. pneumophila* and *L. longbeachae* using the OD~600~ value.

Secondary metabolite identification
-----------------------------------

Secondary metabolites were identified using antiSMASH 3.0 ([@ref-86]) with the optional ClusterFinder algorithm activated. The results from each genome were then aligned using Mauve ([@ref-25]), a BLAST based analysis program, to identify homologous clusters. Using this method, we assembled some clusters that were split across different contigs by sequence similarity, additionally taking into account the predicted substrate specificities and domain modifications from each unassembled module. The sequence for the isocyanide synthase cluster, *isnAB*, was taken from *Xenorhabdus nematophila* ([@ref-23]) and identified in *Legionella* species using BLASTp (v2.2.29) as a part of the BLAST+ suite ([@ref-12]).

Results
=======

Genome of *L. parisiensis*
--------------------------

Purified genomic DNA from *L. parisiensis* DSM 19216 was used for shotgun sequencing. Assembly using Celera (v5.3) revealed a 4,232,283 bp genome with a GC content of 37.98% and was predicted to contain 3,916 protein-coding sequences (CDS). This Whole Genome Shotgun project has been deposited at GenBank under the accession number [LSOG00000000](LSOG00000000). The version described in this paper is version [LSOG01000000](LSOG01000000).

Genome wide analyses
--------------------

Together with the 14 other *Legionella* genomes ([Table 1](#table-1){ref-type="table"}) we identified all protein ortholog families in *Legionella* ([Table S1](#supp-1){ref-type="supplementary-material"}). The core genome of the 15 *Legionella* species consists of 711 coding sequences and includes a type II secretion system as well as the Dot/Icm system. The conserved type II secretion system is essential for intracellular survival and growth ([@ref-45]; [@ref-62]; [@ref-65]) as well as promoting growth at low temperatures ([@ref-77]). The Dot/Icm system is already known to be ubiquitous in all strains ([@ref-33]). The effectors secreted by this system work in concert to evade the phagosome and form the *Legionella*-containing vacuole allowing the bacteria to grow intracellularly ([@ref-49]; [@ref-31]).

Using the program abricate, we additionally analysed the genomes for possible antibiotic resistance genes. In *L. anisa, L. cherrii, L. longbeachae, L. sainthelensis* and *L. wadsworthii* beta-lactamase resistance was identified with no other antibiotic resistance genes present. However, several multi drug efflux pumps were also found in the genomes ([Table S2](#supp-2){ref-type="supplementary-material"}). Using the amino acid sequences of all annotated coding sequences from each strain, we determined ortholog families using proteinortho5 ([@ref-53]). From these ortholog families, we produced a phylogeny representing the gene content based upon the presence or absence of each protein ortholog family. Following analysis of all *Legionella* strains and their BGCs, we constructed a map of each BGC common to more than a single species based on the protein sequence identity ([Figs. 2](#fig-2){ref-type="fig"} and [3](#fig-3){ref-type="fig"}). Bacteriocins are a class of ribosomally synthesized peptides with antibacterial properties. They are classified based on their mode of action and size ([@ref-89]) and are typically used to attack other bacteria competing in similar environments (or sometimes have broad-spectrum activity) but contain resistance mechanisms to avoid self-harm ([@ref-22]). This analysis revealed that there is a range of different bacteriocins present in *Legionella* with all species containing at least one cluster with *L. geestiana*, *L. oakridgensis* and *L. shakespearei* containing bacteriocins not present in any other species ([Figs. 2](#fig-2){ref-type="fig"} and [S1](#supp-5){ref-type="supplementary-material"}; [Table S3](#supp-3){ref-type="supplementary-material"}).

![*Legionella* phylogeny based on presence or absence of ortholog families together with a summary of orthologous BGCs found in two or more *Legionella* species.\
BGCs were identified using antiSMASH ([@ref-86]) and nucleotide sequences were aligned using Mauve ([@ref-25]) to determine those that were similar. Ortholog presence was first determined using proteinortho5 ([@ref-53]). The gene content tree was then constructed using RAxML, based on the presence or absence of each ortholog. BGCs are separated according to the class of compound produced. Cluster letters refer to those genetic schematics shown in [Fig. 3](#fig-3){ref-type="fig"} and compound numbers refer to those found in [Figs. 1](#fig-1){ref-type="fig"} and [6](#fig-6){ref-type="fig"}. A full list of BGCs can be found in [Table S3](#supp-3){ref-type="supplementary-material"}. The gene cluster encoding IsnAB is not detected by antiSMASH but is a known BGC responsible for the biosynthesis of isonitrile containing compounds that are widespread in bacteria ([@ref-6]).](peerj-04-2720-g002){#fig-2}

![Representative examples of BGCs found in multiple *Legionella* species as identified in [Fig. 2](#fig-2){ref-type="fig"}.\
Protein domain architecture as determined from NCBI's conserved domain database for NRPS (green) and PKS (red) encoding genes are also shown. Each circle represents an individual domain of the respective PKS or NRPS (domains not to scale). The PKS from *L. pneumophila* (I) contains a C-terminal condensation domain typical of those seen in NRPSs, which is also capable of polyketide chain release. Clusters O-U can be found in [Fig. S1](#supp-5){ref-type="supplementary-material"}. All clusters are in [Table S3](#supp-3){ref-type="supplementary-material"}.](peerj-04-2720-g003){#fig-3}

Only a single PPTase was identified in *Legionella*, which activates natural product biosynthesis clusters in vitro
-------------------------------------------------------------------------------------------------------------------

Interestingly, the ortholog analysis identified only a single Sfp-like PPTase in all of the analyzed *Legionella* genomes ([Fig. 4](#fig-4){ref-type="fig"}). No AcpS-like PPTase that is usually involved in fatty acid biosynthesis exists ([@ref-57]). PPTases are required to post-translationally attach a 4′-phosphopantetheine arm from CoA to the serine residue contained in the T (ACP or PCP) domain and therefore are essential for fatty acid, polyketide and non-ribosomal peptide biosynthesis ([@ref-85]; [@ref-79]).

![Maximum likelihood phylogeny created using PhyML of PPTases identified in *Legionella* genomes and their relationship to a selection of PPTases from other bacteria.\
Scale represents amino acid substitutions per amino acid position. Bootstrapping (n = 1,000) was used to support branch formation.](peerj-04-2720-g004){#fig-4}

Unsurprisingly, within this group, *Legionella* PPTases form a distinct branch ([Fig. 4](#fig-4){ref-type="fig"}). To test if the *L. parisiensis* Sfp-like PPTase could activate a NRPS, IndC from *Photorhabdus luminescens* ([@ref-5]) and the PPTase from *L. parisiensis* were co-produced in *E. coli* BL21 Star. IndC produces the blue pigment indigoidine by condensation of two glutamines. While indC is constitutively expressed in this experiment, the *L. parisiensis* PPTase gene expression was under control of an IPTG-inducible promoter. Addition of IPTG and consequent PPTase expression led to blue pigment production ([Fig. S2A](#supp-6){ref-type="supplementary-material"}). As the *E. coli* Sfp-type PPTase, EntD, is not capable of activating IndC ([@ref-5]), any production of indigoidine must be activated by the PPTase from *L. parisiensis*. Harvesting and resuspension of the colored cells in water shows a bright blue pigmentation of the IPTG-induced culture ([Fig. S2B](#supp-6){ref-type="supplementary-material"}).

Inhibition of legioliulin production and growth in *L. parisiensis*
-------------------------------------------------------------------

To rule out the possibility that any PPTase was missed in this analysis, we used 2-pyridinyl-*N*-(4-aryl)-piperazine-1-carbothioamides (4--6), specific inhibitors of bacterial Sfp-like PPTases ([@ref-36]), to shut off legioliulin production. Legioliulin production and growth are closely linked. Bacterial growth was measured at OD~600~, and legioliulin production was observed under long-wave UV-light. The addition of 1 μg/mL of inhibitor 4 resulted in a total loss of legioliulin production. We then used different concentrations of 4 to determine substance effectivity ([Fig. 5](#fig-5){ref-type="fig"}). Concentrations as low as 0.4 μg/mL of 4 showed an inhibition in legioliulin biosynthesis and growth. For compounds 5 and 6, initial inhibitory effects were observed at concentrations of 0.75 and 6 μg/mL, respectively. Similarly, growth inhibition was observed for *L. pneumophila* and *L. longbeachae* ([Table S3](#supp-3){ref-type="supplementary-material"}).

![Inhibition of legioliulin production resulting in fluorescence (at 366 nm) in *L. parisiensis* by PPTase inhibitors 4--6.](peerj-04-2720-g005){#fig-5}

Biosynthetic gene clusters
--------------------------

During the secondary metabolite analysis, we used antiSMASH to predict BGCs and extracted all those containing predicted siderophore, PKS, NRPS, lantipeptide or bacteriocin clusters. With the optional ClusterFinder algorithm activated ([@ref-21]), we also examined all putative and saccharide-like clusters for misclassification ([Table S3](#supp-3){ref-type="supplementary-material"}). Strains contained between 15 and 36 BGCs in total with NRPS clusters being the most prevalent. The most widespread PKS, NRPS and siderophore clusters found in *Legionella* are shown in [Fig. 3](#fig-3){ref-type="fig"} highlighting the overall synteny as well as the domain architecture of the natural product synthases.

Non-ribosomal peptide synthetase product predictions in *Legionella*
--------------------------------------------------------------------

PKS and NRPS specificity can often be predicted based upon the DNA sequence and comparisons to experimentally validated studies ([@ref-78]; [@ref-17]; [@ref-88]). In the case of the Stachelhaus code, conserved motifs in the adenylation (A) domain are used to predict substrate specificity. These conserved motifs and their respective specificities were confirmed by single nucleotide mutations resulting in either a loss of, or relaxation of substrate specificity ([@ref-78]). Prediction using a hidden Markov model based approach is also available to predict specificities of either A domains from NRPS or acyltransferase (AT) domains from PKS and is integrated into antiSMASH ([@ref-56]; [@ref-86]). NRPSPredictor2, unlike the previous two methods, uses a support vector machine to predict specificities ([@ref-66]). These methods formed the basis to predict the structures of the natural products produced by BGCs in *Legionella*. In many *Legionella* BGCs, the specificities for A domains involved in the activation of the correct amino acid in the NRPS could either not be predicted or showed variable results when these different algorithms were used. We therefore only attempted to predict resulting structures where a consensus among the three methods was reached. Several low molecular weight natural products produced from monomodular NRPS could be predicted assuming non-iterative use of these NRPS modules ([Fig. 6](#fig-6){ref-type="fig"}).

![Theoretical structures of compounds 7--10 predicted from the clusters B--D, G and I (monomodular NRPS), shown in [Fig. 2](#fig-2){ref-type="fig"}.\
Monomodular NRPS are predicted to produce modified amino acids or dipeptide derivatives that have also been identified in different fungi ([@ref-37]). In a relatively rarely described phenomenon, NRPS domains may be re-used during product biosynthesis resulting in peptides longer than expected from the NRPS domain architecture. An example of such an iterative use is due to the action of the thioesterase domain which, following a single round of biosynthesis, must oligomerize the enzyme bound peptide product before release from the NRPS ([@ref-73]; [@ref-9]; [@ref-47]; [@ref-34]). Due to the relative infrequency that this happens, we assumed non-iterative use of domains for all structural predictions. Cluster B ([Fig. 3](#fig-3){ref-type="fig"}) encodes a NRPS/PKS hybrid that is suggested to produce a valine elongated by a single polyketide elongation using malonyl-CoA with the resulting product, dependent on the thioesterase (TE) function, might be linear (7a) or cyclic (7b). Cluster C encodes a monomodular NRPS that is predicted to produce a *N*-formylated amino acid that is either reduced by the C-terminal reduction (Red) domain to the aldehyde (8a), or the alcohol (8b) that can then by cyclized non-enzymatically to form an oxazoline ring (8c). The acylated amino acid derived from cluster D can undergo similar transformation resulting in structurally related compounds (9a, 9b, 9c). Cluster G and I are very similar to C but the NRPS is terminated by a TE domain resulting again in either a linear (10a) or cyclic product (10b).](peerj-04-2720-g006){#fig-6}

Discussion
==========

Secondary metabolism in *Legionella* is under-pinned by a broad spectrum PPTase
-------------------------------------------------------------------------------

Following the sequencing of the *L. parisiensis* genome, we noted the presence of 32 BGCs, as predicted by antiSMASH ([Table S3](#supp-3){ref-type="supplementary-material"}). We then further investigated a selection of other *Legionella* strains to obtain a snapshot of the secondary metabolite potential of the genus. Through ortholog clustering we looked specifically for genes that are known to be essential in secondary metabolism.

Interestingly, this diversity in secondary metabolites gene clusters appeared to be controlled by a single Sfp-like PPTase in all *Legionella* strains analyzed, L.Ppt (*Legionella* PPTase, [Fig. 4](#fig-4){ref-type="fig"}). This PPTase may therefore be capable of activating all different carrier proteins involved in polyketide and non-ribosomal peptide biosynthesis as well as fatty acid biosynthesis, a part of the primary metabolism as has been seen before ([@ref-55]). A precedent for this has been made in *Pseudomonas aeruginosa*, which carries only a single broad spectrum PPTase that is active in both primary and secondary metabolism ([@ref-72]). However, the veracity of this hypothesis is yet to be definitively determined in *Legionella*. Following identification of only one PPTase, we used an indigoidine production assay to confirm a role for L.Ppt from *L. parisiensis* in secondary metabolism. The enzyme was able to activate the NRPS IndC from *P. luminescens*, even though no NRPS product is known for any *Legionella* strain so far confirming this function. To investigate the effect on suppression of the Sfp-type PPTase, we grew *L. parisiensis* in the presence of Sfp-type PPTase inhibitors ([@ref-36]) and showed that legioliulin production, in addition to cell viability, is halted ([Table S4](#supp-4){ref-type="supplementary-material"}; [Fig. 5](#fig-5){ref-type="fig"}). The importance of this is that if only a single PPTase controls both primary and secondary metabolism, PPTase inhibitors may be effective as monotherapeutic drugs with multi-target effects ([@ref-76]) resulting from the loss of several functional ACP or PCP proteins, inhibiting essential fatty acid and secondary metabolite biosynthesis. Although fatty acid biosynthesis has been questioned as a general target for antibiotic therapy ([@ref-61]), the parallel inhibition of fatty acid, virulence factor and signaling compound biosynthesis might make PPTase inhibitors powerful antibiotics or drugs that could also work against intracellular pathogens, where fatty acid biosynthesis is essential ([@ref-90]).

Reconstruction of BGCs and ortholog clustering highlight the diversity of potential secondary metabolites in *Legionella*
-------------------------------------------------------------------------------------------------------------------------

Only the structures of legioliulin (1), legiobactin (2) and legionellol (3) have been solved ([Fig. 1](#fig-1){ref-type="fig"}) while one other PKS derived compound has been implicated in lysosomal degradation ([@ref-74]). Legioliulin is a *trans*-AT PKS derived fluorophore ([Fig. 3A](#fig-3){ref-type="fig"}). However, beyond fluorescence of bacterial strains containing the gene cluster, a biological function was not defined for legioliulin. This is perhaps unsurprising given that only the strains amoebic intracellular growth capabilities were tested while the species has been isolated from both environmental and clinical sources in both fluorescing and non-fluorescing forms ([@ref-48]). The cluster of coding sequences responsible for legionellol, a hydrophilic molecule involved in lipid scaffolding, has been ascribed to a number of small discrete genes (lpg2223-41) coding for different domains in *L. pneumophila* ([Fig. S3](#supp-7){ref-type="supplementary-material"}) ([@ref-51]).

One disadvantage with short read sequencing technologies is that long gene sequences that are prone to containing repetitive sequences may not be properly assembled. This may be the case for the PKS and NRPS gene clusters that we have examined here, as some are known to be highly repetitive such as the mycolactone PKS ([@ref-81]) or the syringopeptin NRPS ([@ref-69]). Although *Legionella* probably do not contain examples as extreme as mycolactone or syringopeptin, it is possible that the misclassified saccharide-like clusters or some of the contigs containing clusters at their respective termini are in fact collapsed BGCs due to poor assembly. Despite this, we found significant conservation of some BGCs, although this was not always reflected in the phylogenetic tree composed of all coding sequences. For example, Cluster F ([Fig. 2](#fig-2){ref-type="fig"}) is present in species that appear more dissimilar with respect to their gene content. This observation may be in part explained by the amount of horizontal gene transfer that is reported to occur in this genus leading to a greater diversity of coding sequences ([@ref-42]).

Cluster F, the most prevalent cluster, is a NRPS consisting of a single module containing an A, T and C domain, however it was not limited to a given clade of bacteria suggesting it is probably either dispensable for growth and survival, or it plays a more general role. Perhaps more interesting are the clusters that are exclusive to certain clades such as clusters E and K, a NRPS and type III PKS, respectively as well as clusters M and N, which are both siderophores. The apparent maintenance of these clusters in specific clades may be representative of essential functions in their particular environment. However, experimental evidence is needed to verify the veracity of this hypothesis. Siderophores are a well-known virulence factor of many bacteria and the structure of legiobactin (2) has already been elucidated in *L. pneumophila* (Cluster M ([@ref-11])). It is reported as having an identical structure to rhizoferrin ([@ref-28]; [@ref-11]) and is essential for ferric iron uptake during infection of the lungs ([@ref-54]; [@ref-64]; [@ref-2]; [@ref-18]).

Several *Legionella* strains also encode homologs of *isnA* and *isnB* that have been shown to be involved in the biosynthesis of isonitrile containing natural products that are widespread among bacteria ([@ref-6]). Specifically, *isnA* and *isnB* encode proteins that, together, produce an inhibitor of insect phenoloxidase that has been shown to be important in defense against host immune responses in entomopathogenic bacteria ([@ref-6]; [@ref-23]). In *Legionella,* a helix-turn-helix domain protein and a cytochrome P450 oxidase are always associated with the cluster ([Fig. 3L](#fig-3){ref-type="fig"}). In *Pseudomonas,* the *isnAB* cluster is part of a larger BGC and does not make the phenoloxidase inhibitor. There, the IsnAB homologs PvcA and PvcB are encoded as a part of the pyoverdine BGC where they are involved in maturation of the siderophore pyoverdine ([@ref-27]).

Analysis of clusters B--D reveals the presence of NRPS that are clustered with genes encoding a transcriptional regulator. Although not definitive, this provides evidence supporting a role for these products as novel signaling compounds as seen in other Gram-negative bacteria ([@ref-4]; [@ref-7]). If this is indeed the case, its significance lies in the fact that the bacteria occupy a relatively diverse environment and the signals may be specific for their respective niches.

In addition to the more conserved clusters found in several strains, unique clusters have been identified that are present only in individual strains ([Fig. S3](#fig-3){ref-type="fig"}). Among them is another *trans*-AT PKS in *L. cherii* that might be responsible for the described red fluorescence of this strain that also gave it its name. However, the red fluorescence might also be derived from the legioliulin cluster, also encoded in this genome, when a starting unit other than cinnamic acid is used that could result in a red-shift of the resulting fluorophore. Different PKS/NRPS hybrids are encoded in *L. anisa*, *L. parisiensis* and *L. longbeachae* that additionally encode type I PKSs that could also be involved in the production of unusual fatty acids or lipids required for their particular niche ([Fig. S3](#fig-3){ref-type="fig"}).

There are a large number of diverse and interesting BGCs in *Legionella* that have thus far been unexplored. Although few are conserved across species, we cannot rule out the possibility that these BGCs are providing important chemical compounds to their respective strains, whether for signaling, or otherwise. The lack of cluster conservation further reinforces the notion that this genus is a large, untapped reservoir for novel secondary metabolite discovery. Given the association of these bacteria with protozoa in the environment and the interaction of the pathogenic strains with human phagocytic cells, bioactive metabolites originating from this genus may have activity against eukaryotic targets making this an interesting area of future research.

Supplemental Information
========================

10.7717/peerj.2720/supp-1
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Minimal inhibitory concentration (MIC) \[μg/ml\] of compounds **4**--**6** against *L. pneumophila*, *L. longbeachae* and *L. parisiensis*. Mean values of triplicate experiments are shown.
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###### Clusters O-U as specified in [Fig. 2](#fig-2){ref-type="fig"}.

Representative examples of clusters O-U from [Fig. 2](#fig-2){ref-type="fig"}. For a full list of clusters, refer to [Table S3](#supp-3){ref-type="supplementary-material"}.
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###### Indigoidine production in *E. coli* by PPTase from *L. parisiensis*.

pUC18_indC and pCOLA_LparPPTase were used to transform *E. coli* and subsequently induced with IPTG. Indigoidine production can be seen in (**A**) *E. coli* grown in LB medium and more clearly following (**B**) pelleting of the *E. coli* cultures and resuspension in deionized water.
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###### Unique BGCs in *Legionella*.

Selection of unique clusters identified in *Legionella* genomes. The legionellol cluster is shown at the bottom. For a full list of clusters, see [Table S3](#supp-3){ref-type="supplementary-material"}. The domain architecture shown (below PKS (red) and NRPS (green) coding sequences) was determined using NCBI's conserved domain database.
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PKS

:   polyketide synthase

NRPS

:   non-ribosomal peptide synthetase

BGC

:   biosynthetic gene cluster

AT

:   acyltransferase

A

:   adenylation

T

:   thiolation

C

:   condensation

TE

:   thioesterase
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